Med. Chem. Commun. 2016, 7, 224-229.

Efficient synthesis of novel disubstituted pyrido[3,4-b]pyrazines for the design of protein kinase inhibitors.

Bioorg. Med. Chem. Lett. 2014, 24, 3748-3752.

Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells.

ChemMedChem 2014, 9, 217-232.

Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors. 

Synthesis, 2012, 44, 69-82.  

A convenient synthesis of novel 2,8-disubstituted pyrido[3,4-b]pyrazines possessing biological activity.

Synthesis, 2011, 5, 794-806.

Preparation of novel 2,3,8-trisubstituted pyrido[3,4-b]pyrazines and pyrido[2,3-b]pyrazines.

Bioorg. Med. Chem., 2009, 17(18), 6715-6727.

Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.

Tetrahedron 2005, 61, 4035-4041. 

Palladium(II)-catalyzed heterocyclisation of 8-arylethynyl-1,2,3,4-tetrahydroquinolines: a facile route to 2-aryl-5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinoline derivatives.

J. Med. Chem. 1999, 42, 638-648.

New N-(pyridin-4-yl)-(indol-3-yl)acetamides and propanamides as antiallergic agents.

PCT Int. Appl. WO 2011064250, 2011.